MediBuddy makes strides towards achieving EBITDA neutrality, reports ET HealthWorld

MediBuddy, a leading healthcare platform, has achieved significant progress towards EBITDA neutrality, reaching break-even with a marginal loss in the previous fiscal year. The company has experienced a 2.4x growth in its user base over the last three years, serving nearly three crore Indians, with over one crore subscribers. MediBuddy is now focusing on exploring mergers and acquisitions (M&A) opportunities in key healthcare areas such as chronic disease management, mental health, diabetes, women’s care, and weight management, supported by an $18 million capital pool dedicated to these investments.

Co-founder and CEO of MediBuddy, Satish Kannan, emphasized the company’s commitment to empowering doctors through their platform, offering accessible care through various services such as video consultations, hospital visits, clinics, pharmacy deliveries, and diagnostic services. By leveraging technology, MediBuddy enhances doctor-patient interactions, leading to remarkable growth and expanded healthcare access nationwide. The recent integration of vHealth, acquired in 2023, has significantly expanded the platform’s reach, particularly in tier II and tier III areas, catering to a wider range of customers.

With a network of over 90,000+ doctors, 7,100+ hospitals and clinics, 5,000+ diagnostic centres, and 2,500+ pharmacies, MediBuddy has established itself as a comprehensive healthcare solution provider. Additionally, the platform has onboarded over 10,000+ hospitals and diagnostic centres to further enhance its diagnostic capabilities and service offerings.

Overall, MediBuddy’s strategic focus on innovation, expansion, and partnerships in the healthcare sector has propelled its growth and positioned it as a key player in the industry. The company’s dedication to improving healthcare access and services for millions of Indians demonstrates its commitment to transforming the healthcare landscape in the country.